Evidence map›Paper›PMID 25583247›Full record

ArticleSchizophrenia research2015

Plasma oxytocin levels predict olfactory identification and negative symptoms in individuals with schizophrenia.

Gregory P Strauss, William R Keller, James I Koenig, James M Gold, Kathryn L Ossenfort, Robert W Buchanan

Open access · greenAbstract read
In one paragraph

Article in Schizophrenia research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
9.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Gregory P StraussDepartment of Psychology, State University of New York at Binghamton, Binghamton, NY, USA. Electronic address: gstrauss@binghamton.edu.
William R KellerMaryland Psychiatric Research center and Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.
James I KoenigMaryland Psychiatric Research center and Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.
James M GoldMaryland Psychiatric Research center and Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.
Kathryn L OssenfortDepartment of Psychology, State University of New York at Binghamton, Binghamton, NY, USA.
Robert W BuchananMaryland Psychiatric Research center and Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.
University of Maryland, Baltimore · USBinghamton University · US

Funding

Tretment of negative symptoms and cognitive impairment in schizopreniaP50MH082999 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI CARPENTER, WILLIAM T. · 2008 to 2012
$9.7M
NIMH NIH HHS P50 MH082999NIMH NIH HHS P50-MH082999
6 · The paper itself

Abstract

Basic neuroscience research provides strong evidence for the role of oxytocin in olfactory processes and social affiliation in rodents. Given prior indication of olfactory impairments that are linked to greater severity of asociality in schizophrenia, we examined the association between plasma oxytocin levels and measures of olfaction and social outcome in a sample of outpatients with schizophrenia (n=39) and demographically matched healthy controls (n=21). Participants completed the 40-item University of Pennsylvania Smell Identification Test (UPSIT), and rated each odor for how positive and how negative it made them feel. Results indicated that individuals with schizophrenia had higher plasma oxytocin levels and lower overall accuracy for UPSIT items than controls. Individuals with schizophrenia also reported experiencing more negative emotionality than controls in response to the olfactory stimuli. Lower plasma oxytocin levels were associated with poorer accuracy for pleasant and unpleasant odors and greater severity of asociality in individuals with schizophrenia. These findings suggest that endogenous oxytocin levels may be an important predictor of olfactory identification deficits and negative symptoms in schizophrenia.

Indexed as

AdultFemaleHumansInterview, PsychologicalMaleNeuropsychological TestsOdorantsOlfactory PerceptionOxytocinPattern Recognition, PhysiologicalPhysical StimulationPsychiatric Status Rating ScalesSchizophreniaSchizophrenic PsychologyOxytocinEmotionHedonicNegative symptomsOlfactionOxytocinPsychosis

Identifiers

PMID25583247
PMCPMC4339311
OpenAlexW2092870960

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.